LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer

• Main Authors: Ying Zeng (Author), Guo Wang (Author), Cheng-Fang Zhou (Author), Hai-Bo Zhang (Author), Hong Sun (Author), Wei Zhang (Author), Hong-Hao Zhou (Author), Rong Liu (Author), Yuan-Shan Zhu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundThe purpose of this study is to develop an effective but concise long non-coding RNA (lncRNA) expression signature that can predict response to neoadjuvant chemotherapy for breast cancer (BC) patients.MethodslncRNA expression profiling in 1102 BC patients from Gene Expression Omnibus datas...